BioSpace News Archive

Cytokinetics, Incorporated announced that Fady I. Malik, M.D., Ph.D., Executive Vice President, Research & Development, is scheduled to participate in the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019 at 12:05 PM MT at The Phoenician in Scottsdale, AZ.

Dosed First Patient in Phase 3 Study of APL-2 for Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria

Third quarter 2019 revenue of $16.0 million, an increase of 16% over the third quarter of 2018

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa

InspireMD, Inc. announced that it will host a conference call and webcast on Tuesday, November 12, 2019, to discuss financial results for the third quarter and nine months ended September 30, 2019, and provide a corporate update.

Cue Biopharma, Inc. announced it will host a conference call and webcast to provide a business update on Tuesday, November 12, 2019 at 4:30 p.m. ET.

Axovant Gene Therapies, Ltd., a clinical-stage company developing innovative gene therapies, announced that Pavan Cheruvu, M.D., chief executive officer, will present at the following investor conferences

ImmuCell Corporation - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle - will report unaudited financial results for the quarter ended September 30, 2019 after the market closes on Monday, November 11, 2019.

Additional data demonstrate potential of CD73 inhibitor CB-708 to combine with immuno-oncology and chemotherapy agents in solid tumors

Gritstone Oncology, Inc. announced data on novel shared tumor-specific neoantigens arising from recurrent cancer driver mutations that have been identified by its EDGE platform.